Tanaka, A., Shimabukuro, M., Teragawa, H., Okada, Y., Takamura, T., Taguchi, I., . . . Node, K. (2021). Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin. Cardiovasc Diabetol.
Chicago Style CitationTanaka, Atsushi, et al. "Comparison of the Clinical Effect of Empagliflozin On Glycemic and Non-glycemic Parameters in Japanese Patients With Type 2 Diabetes and Cardiovascular Disease Treated With or Without Baseline Metformin." Cardiovasc Diabetol 2021.
Cita MLATanaka, Atsushi, et al. "Comparison of the Clinical Effect of Empagliflozin On Glycemic and Non-glycemic Parameters in Japanese Patients With Type 2 Diabetes and Cardiovascular Disease Treated With or Without Baseline Metformin." Cardiovasc Diabetol 2021.